|
Pillar 2: Partnerships & Collaborations
|
Build strategic partnerships to amplify impact and deliver shared outcomes.
- Joint initiatives with colleges, societies, and clinical groups
- Cross‑sector partnerships with government, industry, and research organisations
- Trans‑Tasman collaboration to strengthen shared priorities
- Participation in panels, roundtables, and advisory groups
- Collaborative models that support predictive, preventative, and personalised care
HSANZ will shift from informal relationships to structured, strategic partnerships; formalising links with key bodies and diversifying its funding base.
Formalise relationships with government bodies, research bodies and other haematology organisations through partnership agreements.
Consolidate education efforts with local, Trans-Pacific and Asia-Pacific partners, including publication of Blood Conference meeting abstracts.
Diversify funding sources, via partnerships with universities, government, and philanthropic foundations.
Prioritise opportunities for engaging younger trainees and researchers.
Details of planned projects for Pillar 2: |
Project 1. Blood Abstract Publication — Publish and promote Blood meeting abstracts to increase visibility and academic value Timeline: Now - Underway (0-12 months, Phase 1) Progress Report: Project underway. Operating procedure and abstract review process and formalise the abstract review committees - before July 2026 Council meeting - dispel rules about ASH and EHA restrictions. | Project 2. Cross-Society Collaboration — Partner with ANZSBT and THANZ on education, events and membership alignment Work with ANZSBT & THANZ to co-host educational content and joint membership. Make use of Blood branding. Timeline: Now (0-12 months, Phase 1) | Project 3. Asia-Pacific Partnerships — Build strategic relationships with regional and international organisations RCPA had an international efforts committee previously. HOA brings together Asia Pacific networks together, potential to leverage off this? A small session/networking opportunity for those interested in international work? An overseas membership? Subsidised if partnered with their local Society. Timeline: Later (3-5 years, Phase 3) | Project 4. ALLG Collaboration — Strengthen collaboration across education, advocacy and training initiatives Define areas for collaboration. ALLG and Blood meetings. Advocacy. Possible ALLG Training day and HSANZ; regular meeting with ALLG. Timeline: Now (0-12 months, Phase 1) |
Project 5. Non-Pharma Funding — Develop diversified funding through sponsorships, grants and partnerships Fundraising, corporate sponsorships, grants for the Society to pursue. Be on the list of fundraising platforms "Grassroots". Timeline: Later (3-5 years, Phase 3) | Project 6. Trainee Engagement — Understand and address HSANZ engagement challenges and opportunities among haematology trainees Ties in with Pillar 1.Workforce & Career. Develop a scoping report and develop strategies to reach trainees. Understand how to attract the next generation of haematology professionals to play a part in HSANZ. Timeline: Now (0-12 months, Phase 1) | Project 7. Strategic Partnerships — Shift from informal relationships to structured, prioritised partnerships Ensure HSANZ is seen as a proactive leader in convening haematology Societies and organisations. Establish ongoing discussions with EHA and ASH. Ongoing discussions of shared advocacy points. Investigate opportunities with EHA and ASH training groups & HOA & HOA Training Institute. Prioritise key stakeholders. eg. ASH/EHA joint plenary; HSANZ to invite a EHA or ASH and nurse speaker at Blood. Timeline: Next (1-3 years, Phase 2) |
|
|
© 2026 Haematology Society of Australia & New Zealand. All Rights Reserved.